HaploReg

Build Query

Use one of the three methods below to enter a set of variants. If an r² threshold is specified (see the Set Options tab), results for each variant will be shown in a separate table along with other variants in LD. If r² is set to NA, only queried variants will be shown, together in one table.

Query (refSNP ID(s), comma-delimited):
or, upload a text file (one refSNP ID per line):
or, select a GWAS:	5-HTT brain serotonin transporter levels (Liu et al., 2011), 1 SNPAbdominal aortic aneurysm (Gretarsdottir et al., 2010), 2 SNPsAcenocoumarol maintenance dosage (Teichert et al., 2009), 4 SNPsActivated partial thromboplastin time (Houlihan et al., 2010), 3 SNPsAcute lymphoblastic leukemia (2 studies combined), 17 SNPsAcute lymphoblastic leukemia (childhood) (Papaemmanuil et al., 2009), 3 SNPsAcute lymphoblastic leukemia (childhood) (Treviño et al., 2009), 14 SNPsAdiponectin levels (5 studies combined), 9 SNPsAdiponectin levels (Heid et al., 2009), 1 SNPAdiponectin levels (Jee et al., 2010), 1 SNPAdiponectin levels (Ling et al., 2009), 2 SNPsAdiponectin levels (Richards et al., 2009), 3 SNPsAdiponectin levels (Wu et al., 2010), 3 SNPsAdiposity (Lindgren et al., 2009), 4 SNPsAdverse response to aromatase inhibitors (2 studies combined), 2 SNPsAdverse response to aromatase inhibitors (Ingle et al., 2010), 1 SNPAdverse response to aromatase inhibitors (Ingle et al., 2010), 1 SNPAdverse response to carbamapezine (McCormack et al., 2011), 1 SNPAge-related macular degeneration (5 studies combined), 25 SNPsAge-related macular degeneration (Chen et al., 2010), 12 SNPsAge-related macular degeneration (Kopplin et al., 2010), 4 SNPsAge-related macular degeneration (Neale et al., 2010), 11 SNPsAge-related macular degeneration (wet) (Dewan et al., 2006), 1 SNPAge-related macular degeneration (Yu et al., 2011), 11 SNPsAging (Poduslo et al., 2009), 1 SNPAIDS (Clerc et al., 2009), 7 SNPsAIDS progression (2 studies combined), 10 SNPsAIDS progression (Limou et al., 2009), 3 SNPsAIDS progression (Troyer et al., 2011), 7 SNPsAlcohol consumption (2 studies combined), 5 SNPsAlcohol consumption (Baik et al., 2011), 4 SNPsAlcohol consumption (Schumann et al., 2011), 1 SNPAlcohol dependence (2 studies combined), 9 SNPsAlcohol dependence (Kendler et al., 2011), 3 SNPsAlcohol dependence (Treutlein et al., 2009), 6 SNPsAlcoholism (heaviness of drinking) (Heath et al., 2011), 22 SNPsAlopecia areata (Petukhova et al., 2010), 8 SNPsAlzheimer's disease (20 studies combined), 42 SNPsAlzheimer's disease (Abraham et al., 2008), 2 SNPsAlzheimer's disease (Antunez et al., 2011), 5 SNPsAlzheimer's disease (Beecham et al., 2009), 3 SNPsAlzheimer's disease (Bertram et al., 2008), 2 SNPsAlzheimer's disease (Carrasquillo et al., 2009), 1 SNPAlzheimer's disease (Feulner et al., 2009), 1 SNPAlzheimer's disease (Harold et al., 2009), 3 SNPsAlzheimer's disease (Heinzen et al., 2009), 5 SNPsAlzheimer's disease (Hollingworth et al., 2011), 4 SNPsAlzheimer's disease (Kramer et al., 2010), 2 SNPsAlzheimer's disease (Lambert et al., 2009), 3 SNPsAlzheimer's disease (late onset) (Coon et al., 2007), 1 SNPAlzheimer's disease (late onset) (Hu et al., 2011), 2 SNPsAlzheimer's disease (late onset) (Naj et al., 2010), 4 SNPsAlzheimer's disease (late onset) (Naj et al., 2011), 9 SNPsAlzheimer's disease (late onset) (Reiman et al., 2007), 1 SNPAlzheimer's disease (late onset) (Wijsman et al., 2011), 1 SNPAlzheimer's disease (Li et al., 2007), 1 SNPAlzheimer's disease (Seshadri et al., 2010), 1 SNPAlzheimer's disease (Webster et al., 2007), 1 SNPAlzheimer's disease biomarkers (Kim et al., 2010), 7 SNPsAmyloid A Levels (Marzi et al., 2010), 3 SNPsAmyotrophic lateral sclerosis (9 studies combined), 38 SNPsAmyotrophic lateral sclerosis (Cronin et al., 2007), 1 SNPAmyotrophic lateral sclerosis (Cronin et al., 2008), 1 SNPAmyotrophic lateral sclerosis (Laaksovirta et al., 2010), 2 SNPsAmyotrophic lateral sclerosis (Landers et al., 2009), 16 SNPsAmyotrophic lateral sclerosis (Schymick et al., 2007), 6 SNPsAmyotrophic lateral sclerosis (Shatunov et al., 2010), 4 SNPsAmyotrophic lateral sclerosis (van Es et al., 2007), 1 SNPAmyotrophic lateral sclerosis (van Es et al., 2007), 3 SNPsAmyotrophic lateral sclerosis (van Es et al., 2009), 8 SNPsAngiotensin-converting enzyme activity (Chung et al., 2010), 2 SNPsAnkylosing spondylitis (Reveille et al., 2010), 9 SNPsAnorexia nervosa (Wang et al., 2010), 9 SNPsAnthropometric traits (Polasek et al., 2009), 12 SNPsAnti-cyclic Citrullinated Peptide Antibody (Cui et al., 2009), 1 SNPAntipsychotic-induced QTc interval prolongation (Aberg et al., 2010), 3 SNPsAortic root size (Wineinger et al., 2011), 7 SNPsArterial stiffness (Tarasov et al., 2009), 1 SNPArthritis (2 studies combined), 2 SNPsArthritis (juvenile idiopathic) (Behrens et al., 2008), 1 SNPArthritis (juvenile idiopathic) (Hinks et al., 2009), 1 SNPAsperger disorder (Salyakina et al., 2010), 5 SNPsAsthma (8 studies combined), 21 SNPsAsthma (childhood onset) (Hancock et al., 2009), 1 SNPAsthma (Ferreira et al., 2010), 1 SNPAsthma (Himes et al., 2009), 1 SNPAsthma (Li et al., 2010), 3 SNPsAsthma (Moffatt et al., 2007), 1 SNPAsthma (Moffatt et al., 2010), 10 SNPsAsthma (Sleiman et al., 2009), 1 SNPAsthma (toluene diisocyanate-induced) (Kim et al., 2009), 3 SNPsAtopic dermatitis (2 studies combined), 2 SNPsAtopic dermatitis (Esparza-Gordillo et al., 2009), 1 SNPAtopic dermatitis (Sun et al., 2011), 1 SNPAtopy (Castro-Giner et al., 2009), 1 SNPAtrial fibrillation (3 studies combined), 8 SNPsAtrial fibrillation (Benjamin et al., 2009), 3 SNPsAtrial fibrillation (Ellinor et al., 2010), 3 SNPsAtrial fibrillation (Gudbjartsson et al., 2009), 2 SNPsAtrial fibrillation/atrial flutter (Gudbjartsson et al., 2007), 2 SNPsAtrioventricular conduction (Denny et al., 2010), 5 SNPsAttention deficit hyperactivity disorder (4 studies combined), 49 SNPsAttention deficit hyperactivity disorder (Lesch et al., 2008), 26 SNPsAttention deficit hyperactivity disorder (Mick et al., 2008), 2 SNPsAttention deficit hyperactivity disorder (Mick et al., 2010), 10 SNPsAttention deficit hyperactivity disorder (time to onset) (Lasky-Su et al., 2008), 11 SNPsAttention deficit hyperactivity disorder and conduct disorder (Anney et al., 2008), 26 SNPsAttention deficit hyperactivity disorder motor coordination (Fliers et al., 2011), 1 SNPAutism (4 studies combined), 5 SNPsAutism (Anney et al., 2010), 2 SNPsAutism (Ma et al., 2009), 1 SNPAutism (Wang et al., 2009), 1 SNPAutism (Weiss et al., 2009), 1 SNPBasal cell carcinoma (cutaneous) (Stacey et al., 2008), 2 SNPsBehcet's disease (2 studies combined), 4 SNPsBehcet's disease (Mizuki et al., 2010), 2 SNPsBehcet's disease (Remmers et al., 2010), 2 SNPsBeta thalassemia/hemoglobin E disease (Nuinoon et al., 2009), 3 SNPsBiliary atresia (Garcia-Barceló et al., 2010), 3 SNPsBilirubin levels (2 studies combined), 8 SNPsBilirubin levels (Bielinski et al., 2011), 5 SNPsBilirubin levels (Sanna et al., 2009), 3 SNPsBiochemical measures (Zemunik et al., 2009), 17 SNPsBipolar disorder (7 studies combined), 41 SNPsBipolar disorder (age of onset and psychomotor symptoms) (Mahon et al., 2011), 2 SNPsBipolar disorder (Baum et al., 2007), 1 SNPBipolar disorder (Cichon et al., 2011), 1 SNPBipolar disorder (Ferreira et al., 2008), 21 SNPsBipolar disorder (Lee et al., 2010), 2 SNPsBipolar disorder (Scott et al., 2009), 13 SNPsBipolar disorder (Smith et al., 2009), 1 SNPBipolar disorder and major depressive disorder (combined) (Liu et al., 2010), 9 SNPsBipolar disorder and schizophrenia (2 studies combined), 56 SNPsBipolar disorder and schizophrenia (Curtis et al., 2010), 6 SNPsBipolar disorder and schizophrenia (Wang et al., 2010), 50 SNPsBirth weight (Freathy et al., 2010), 2 SNPsBitter taste response (Reed et al., 2010), 1 SNPBlack vs. red hair color (Han et al., 2008), 14 SNPsBladder cancer (2 studies combined), 9 SNPsBladder cancer (Rothman et al., 2010), 9 SNPsBladder cancer (Wu et al., 2009), 1 SNPBleomycin sensitivity (Gu et al., 2010), 3 SNPsBlood lipid traits (Teslovich et al., 2010), 2 SNPsBlood pressure (Wang et al., 2008), 1 SNPBody mass (lean) (Liu et al., 2009), 1 SNPBody mass in chronic obstructive pulmonary disease (Wan et al., 2010), 1 SNPBody mass index (4 studies combined), 48 SNPsBody mass index (Frayling et al., 2007), 1 SNPBody mass index (Loos et al., 2008), 2 SNPsBody mass index (Speliotes et al., 2010), 38 SNPsBody mass index (Willer et al., 2008), 11 SNPsBone mineral density (9 studies combined), 57 SNPsBone mineral density (Duncan et al., 2011), 9 SNPsBone mineral density (Guo et al., 2009), 2 SNPsBone mineral density (Kung et al., 2010), 1 SNPBone mineral density (Paternoster et al., 2010), 1 SNPBone mineral density (Richards et al., 2008), 2 SNPsBone mineral density (spine) (Rivadeneira et al., 2009), 29 SNPsBone mineral density (spine) (Styrkarsdottir et al., 2008), 15 SNPsBone mineral density (spine) (Styrkarsdottir et al., 2008), 14 SNPsBone mineral density (Xiong et al., 2009), 2 SNPsBrain imaging (Shen et al., 2010), 10 SNPsBrain imaging in schizophrenia (interaction) (Potkin et al., 2008), 6 SNPsBrain structure (Stein et al., 2010), 19 SNPsBreast cancer (14 studies combined), 35 SNPsBreast cancer (Antoniou et al., 2010), 1 SNPBreast cancer (Easton et al., 2007), 6 SNPsBreast cancer (Fletcher et al., 2011), 9 SNPsBreast cancer (Gaudet et al., 2010), 1 SNPBreast cancer (Gold et al., 2008), 1 SNPBreast cancer (Hunter et al., 2007), 1 SNPBreast cancer (Kibriya et al., 2008), 1 SNPBreast cancer (Li et al., 2010), 4 SNPsBreast cancer (Long et al., 2010), 1 SNPBreast cancer (Sehrawat et al., 2011), 2 SNPsBreast cancer (Stacey et al., 2007), 2 SNPsBreast cancer (Thomas et al., 2009), 6 SNPsBreast cancer (Turnbull et al., 2010), 13 SNPsBreast cancer (Zheng et al., 2009), 1 SNPC-reactive protein (6 studies combined), 38 SNPsC-reactive protein (Dehghan et al., 2011), 20 SNPsC-reactive protein (Elliott et al., 2009), 5 SNPsC-reactive protein (Okada et al., 2010), 4 SNPsC-reactive protein (Reiner et al., 2008), 3 SNPsC-reactive protein (Ridker et al., 2008), 7 SNPsC-reactive protein (Wu et al., 2011), 3 SNPsCaffeine consumption (Cornelis et al., 2011), 10 SNPsCardiac hypertrophy (Parsa et al., 2011), 19 SNPsCardiac structure and function (Vasan et al., 2009), 10 SNPsCardiovascular disease risk factors (2 studies combined), 8 SNPsCardiovascular disease risk factors (Reilly et al., 2011), 2 SNPsCardiovascular disease risk factors (Smith et al., 2010), 6 SNPsCarotid atherosclerosis in HIV infection (Shrestha et al., 2010), 7 SNPsCaudate nucleus volume (Stein et al., 2011), 2 SNPsCD4:CD8 lymphocyte ratio (Ferreira et al., 2009), 2 SNPsCeliac disease (3 studies combined), 43 SNPsCeliac disease (Dubois et al., 2010), 40 SNPsCeliac disease (Hunt et al., 2008), 8 SNPsCeliac disease (van Heel et al., 2007), 2 SNPsCeliac disease and Rheumatoid arthritis (Zhernakova et al., 2011), 15 SNPsCentral corneal thickness (2 studies combined), 6 SNPsCentral corneal thickness (Lu et al., 2010), 2 SNPsCentral corneal thickness (Vitart et al., 2010), 5 SNPsCholesterol (Igl et al., 2010), 1 SNPChronic Hepatitis C infection (Rauch et al., 2010), 1 SNPChronic kidney disease (Köttgen et al., 2010), 28 SNPsChronic kidney disease and serum creatinine levels (Gudbjartsson et al., 2010), 4 SNPsChronic lymphocytic leukemia (3 studies combined), 17 SNPsChronic lymphocytic leukemia (Bernardo et al., 2008), 6 SNPsChronic lymphocytic leukemia (Crowther-Swanepoel et al., 2010), 7 SNPsChronic lymphocytic leukemia (Slager et al., 2010), 4 SNPsChronic myeloid leukemia (Kim et al., 2011), 2 SNPsChronic obstructive pulmonary disease (2 studies combined), 5 SNPsChronic obstructive pulmonary disease (Cho et al., 2010), 3 SNPsChronic obstructive pulmonary disease (Pillai et al., 2009), 2 SNPsCleft lip (Beaty et al., 2010), 2 SNPsCoffee consumption (Sulem et al., 2011), 2 SNPsCognitive performance (Need et al., 2009), 47 SNPsCognitive test performance (Cirulli et al., 2010), 50 SNPsColorectal cancer (8 studies combined), 18 SNPsColorectal cancer (Broderick et al., 2007), 1 SNPColorectal cancer (Cui et al., 2011), 2 SNPsColorectal cancer (Houlston et al., 2008), 4 SNPsColorectal cancer (Houlston et al., 2010), 5 SNPsColorectal cancer (Tenesa et al., 2008), 3 SNPsColorectal cancer (Tomlinson et al., 2007), 1 SNPColorectal cancer (Tomlinson et al., 2008), 5 SNPsColorectal cancer (Zanke et al., 2007), 1 SNPConduct disorder (2 studies combined), 45 SNPsConduct disorder (interaction) (Sonuga-Barke et al., 2008), 22 SNPsConduct disorder (symptom count) (Dick et al., 2010), 26 SNPsCorneal curvature (Han et al., 2011), 2 SNPsCoronary heart disease (8 studies combined), 103 SNPsCoronary heart disease (Erdmann et al., 2009), 2 SNPsCoronary heart disease (Erdmann et al., 2010), 1 SNPCoronary heart disease (Genetics et al., 2011), 19 SNPsCoronary heart disease (Lettre et al., 2011), 44 SNPsCoronary heart disease (Samani et al., 2007), 7 SNPsCoronary heart disease (Schunkert et al., 2011), 30 SNPsCoronary heart disease (Trégouët et al., 2009), 2 SNPsCoronary heart disease (Wild et al., 2011), 5 SNPsCoronary spasm (Suzuki et al., 2007), 1 SNPCreutzfeldt-Jakob disease (Mead et al., 2008), 2 SNPsCrohn's disease (8 studies combined), 96 SNPsCrohn's disease (Barrett et al., 2008), 30 SNPsCrohn's disease (Franke et al., 2007), 3 SNPsCrohn's disease (Franke et al., 2010), 50 SNPsCrohn's disease (Libioulle et al., 2007), 3 SNPsCrohn's disease (McGovern et al., 2010), 7 SNPsCrohn's disease (Parkes et al., 2007), 9 SNPsCrohn's disease (Raelson et al., 2007), 3 SNPsCrohn's disease (Rioux et al., 2007), 4 SNPsCrohn's disease and Celiac disease (Festen et al., 2011), 2 SNPsCrohn's disease and sarcoidosis (combined) (Franke et al., 2008), 1 SNPCutaneous nevi (2 studies combined), 5 SNPsCutaneous nevi (Falchi et al., 2009), 2 SNPsCutaneous nevi (Nan et al., 2011), 3 SNPsCystic fibrosis severity (Wright et al., 2011), 6 SNPsD-dimer levels (Smith et al., 2011), 15 SNPsDepression--quantitative trait (Terracciano et al., 2010), 11 SNPsDiabetic nephropathy (2 studies combined), 6 SNPsDiabetic nephropathy (Maeda et al., 2007), 1 SNPDiabetic nephropathy (McDonough et al., 2010), 5 SNPsDiabetic retinopathy (2 studies combined), 27 SNPsDiabetic retinopathy (Grassi et al., 2011), 19 SNPsDiabetic retinopathy (Huang et al., 2011), 8 SNPsDialysis-related mortality (Murea et al., 2011), 26 SNPsDigit length ratio (Medland et al., 2010), 1 SNPDilated cardiomyopathy (Villard et al., 2011), 2 SNPsDrinking behavior (Takeuchi et al., 2011), 2 SNPsDrug-induced liver injury (2 studies combined), 8 SNPsDrug-induced liver injury (amoxicillin-clavulanate) (Lucena et al., 2011), 2 SNPsDrug-induced liver injury (flucloxacillin) (Daly et al., 2009), 6 SNPsDupuytren's disease (Ojwang et al., 2010), 1 SNPElectrocardiographic conduction measures (Smith et al., 2009), 7 SNPsElectrocardiographic traits (2 studies combined), 17 SNPsElectrocardiographic traits (Chambers et al., 2010), 3 SNPsElectrocardiographic traits (Holm et al., 2010), 18 SNPsEmphysema-related traits (Kong et al., 2010), 7 SNPsEnd-stage renal disease (2 studies combined), 2 SNPsEnd-stage renal disease (Hanson et al., 2007), 1 SNPEnd-stage renal disease (non-diabetic) (Bostrom et al., 2010), 1 SNPEndometrial cancer (Spurdle et al., 2011), 2 SNPsEndometriosis (3 studies combined), 7 SNPsEndometriosis (Adachi et al., 2010), 2 SNPsEndometriosis (Painter et al., 2010), 3 SNPsEndometriosis (Uno et al., 2010), 2 SNPsEosinophilic esophagitis (pediatric) (Rothenberg et al., 2010), 14 SNPsErectile dysfunction and prostate cancer treatment (Kerns et al., 2010), 23 SNPsEsophageal cancer (2 studies combined), 13 SNPsEsophageal cancer (Cui et al., 2009), 2 SNPsEsophageal cancer (Wu et al., 2011), 11 SNPsEsophageal cancer and gastric cancer (Abnet et al., 2010), 4 SNPsEssential tremor (Stefansson et al., 2009), 1 SNPEvent-related brain oscillations (Zlojutro et al., 2010), 3 SNPsExercise (leisure time) (Moor et al., 2009), 3 SNPsExercise treadmill test traits (Vasan et al., 2007), 13 SNPsEye color traits (Liu et al., 2010), 3 SNPsF-cell distribution (2 studies combined), 12 SNPsF-cell distribution (Bhatnagar et al., 2011), 11 SNPsF-cell distribution (Menzel et al., 2007), 2 SNPsFasting insulin-related traits (Dupuis et al., 2010), 34 SNPsFasting plasma glucose (6 studies combined), 14 SNPsFasting plasma glucose (Bouatia-Naji et al., 2008), 1 SNPFasting plasma glucose (Bouatia-Naji et al., 2008), 1 SNPFasting plasma glucose (Chambers et al., 2009), 1 SNPFasting plasma glucose (Chen et al., 2008), 1 SNPFasting plasma glucose (Meigs et al., 2007), 11 SNPsFasting plasma glucose (Prokopenko et al., 2008), 3 SNPsFetal hemoglobin levels (Uda et al., 2008), 2 SNPsFibrinogen (2 studies combined), 10 SNPsFibrinogen (Danik et al., 2009), 6 SNPsFibrinogen (Dehghan et al., 2009), 4 SNPsFolate pathway vitamin levels (Tanaka et al., 2009), 5 SNPsFollicular lymphoma (3 studies combined), 4 SNPsFollicular lymphoma (Conde et al., 2010), 3 SNPsFollicular lymphoma (Skibola et al., 2009), 1 SNPFollicular lymphoma (Smedby et al., 2011), 1 SNPFuchs's corneal dystrophy (Baratz et al., 2010), 2 SNPsFunctional MRI (Liu et al., 2010), 2 SNPsGallstones (Buch et al., 2007), 1 SNPGlaucoma (4 studies combined), 6 SNPsGlaucoma (Burdon et al., 2011), 2 SNPsGlaucoma (exfoliation) (Thorleifsson et al., 2007), 1 SNPGlaucoma (Meguro et al., 2010), 2 SNPsGlaucoma (primary open-angle) (Thorleifsson et al., 2010), 1 SNPGlioma (3 studies combined), 12 SNPsGlioma (high-grade) (Wrensch et al., 2009), 3 SNPsGlioma (Sanson et al., 2011), 7 SNPsGlioma (Shete et al., 2009), 7 SNPsGlomerulosclerosis (Genovese et al., 2010), 1 SNPGlycated hemoglobin levels (3 studies combined), 16 SNPsGlycated hemoglobin levels (Franklin et al., 2010), 1 SNPGlycated hemoglobin levels (Paré et al., 2008), 4 SNPsGlycated hemoglobin levels (Soranzo et al., 2010), 11 SNPsHair color (Eriksson et al., 2010), 40 SNPsHair morphology (Medland et al., 2009), 15 SNPsHandedness in dyslexia (Scerri et al., 2010), 1 SNPHDL cholesterol (2 studies combined), 4 SNPsHDL cholesterol (Heid et al., 2008), 3 SNPsHDL cholesterol (Ridker et al., 2009), 1 SNPHearing impairment (Laer et al., 2010), 2 SNPsHeart failure (Smith et al., 2010), 16 SNPsHeart rate variability traits (Newton-Cheh et al., 2007), 4 SNPsHeight (16 studies combined), 205 SNPsHeight (Allen et al., 2010), 50 SNPsHeight (Cho et al., 2009), 13 SNPsHeight (Estrada et al., 2009), 5 SNPsHeight (Gudbjartsson et al., 2008), 52 SNPsHeight (Johansson et al., 2008), 1 SNPHeight (Kim et al., 2009), 15 SNPsHeight (Kim et al., 2010), 1 SNPHeight (Lei et al., 2008), 1 SNPHeight (Lettre et al., 2008), 18 SNPsHeight (Liu et al., 2010), 10 SNPsHeight (Okada et al., 2010), 25 SNPsHeight (Sanna et al., 2008), 5 SNPsHeight (Soranzo et al., 2009), 20 SNPsHeight (Tönjes et al., 2009), 1 SNPHeight (Weedon et al., 2007), 1 SNPHeight (Weedon et al., 2008), 20 SNPsHematological and biochemical traits (Kamatani et al., 2010), 50 SNPsHematology traits (Ferreira et al., 2009), 6 SNPsHemoglobin (Chambers et al., 2009), 2 SNPsHemostatic factors and hematological phenotypes (Yang et al., 2007), 22 SNPsHepatitis B (Kamatani et al., 2009), 1 SNPHepatocellular carcinoma (3 studies combined), 6 SNPsHepatocellular carcinoma (Clifford et al., 2010), 3 SNPsHepatocellular carcinoma (Kumar et al., 2011), 2 SNPsHepatocellular carcinoma (Zhang et al., 2010), 1 SNPHip bone size (Liu et al., 2008), 1 SNPHip geometry (Kiel et al., 2007), 24 SNPsHippocampal atrophy (Potkin et al., 2009), 21 SNPsHirschsprung's disease (Garcia-Barcelo et al., 2009), 2 SNPsHIV-1 control (3 studies combined), 55 SNPsHIV-1 control (Fellay et al., 2009), 42 SNPsHIV-1 control (Pelak et al., 2010), 10 SNPsHIV-1 control (Pereyra et al., 2010), 8 SNPsHIV-1 replication (Bol et al., 2011), 1 SNPHIV-1 susceptibility (Petrovski et al., 2010), 6 SNPsHoarding (Perroud et al., 2010), 3 SNPsHodgkin's lymphoma (Enciso-Mora et al., 2010), 5 SNPsHomocysteine levels (Lange et al., 2010), 1 SNPHypertension (5 studies combined), 19 SNPsHypertension (Adeyemo et al., 2009), 2 SNPsHypertension (Org et al., 2009), 1 SNPHypertension (Padmanabhan et al., 2010), 1 SNPHypertension (Slavin et al., 2011), 14 SNPsHypertension (young onset) (Yang et al., 2009), 1 SNPHypertriglyceridemia (Johansen et al., 2010), 5 SNPsHypospadias (Zanden et al., 2010), 1 SNPIdiopathic pulmonary fibrosis (Mushiroda et al., 2008), 1 SNPIleal carcinoids (Walsh et al., 2010), 4 SNPsImmunoglobulin A (Ferreira et al., 2010), 12 SNPsInattentive symptoms (Lasky-Su et al., 2008), 48 SNPsInflammatory bowel disease (3 studies combined), 12 SNPsInflammatory bowel disease (Duerr et al., 2006), 3 SNPsInflammatory bowel disease (early onset) (Imielinski et al., 2009), 4 SNPsInflammatory bowel disease (Kugathasan et al., 2008), 6 SNPsInformation processing speed (Luciano et al., 2010), 25 SNPsInsulin-like growth factors (Kaplan et al., 2011), 8 SNPsInterleukin-18 levels (He et al., 2010), 2 SNPsIntracranial aneurysm (2 studies combined), 8 SNPsIntracranial aneurysm (Bilguvar et al., 2008), 4 SNPsIntracranial aneurysm (Yasuno et al., 2010), 6 SNPsIris color (Kayser et al., 2008), 1 SNPIschemic stroke (Gretarsdottir et al., 2008), 1 SNPKawasaki disease (3 studies combined), 6 SNPsKawasaki disease (Burgner et al., 2009), 2 SNPsKawasaki disease (Kim et al., 2011), 2 SNPsKawasaki disease (Tsai et al., 2011), 2 SNPsKeloid (Nakashima et al., 2010), 4 SNPsKidney stones (Thorleifsson et al., 2009), 1 SNPKnee osteoarthritis (2 studies combined), 3 SNPsKnee osteoarthritis (Nakajima et al., 2010), 1 SNPKnee osteoarthritis (Valdes et al., 2008), 2 SNPsLarge B-cell lymphoma (Kumar et al., 2011), 2 SNPsLDL cholesterol (4 studies combined), 6 SNPsLDL cholesterol (Burkhardt et al., 2008), 2 SNPsLDL cholesterol (Hiura et al., 2009), 1 SNPLDL cholesterol (Sandhu et al., 2008), 3 SNPsLDL cholesterol (Shen et al., 2010), 2 SNPsLeft ventricular mass (2 studies combined), 3 SNPsLeft ventricular mass (Arnett et al., 2009), 2 SNPsLeft ventricular mass (Arnett et al., 2011), 3 SNPsLeprosy (Zhang et al., 2009), 6 SNPsLipoprotein-associated phospholipase A2 activity and mass (Suchindran et al., 2010), 5 SNPsLongevity (3 studies combined), 30 SNPsLongevity (Malovini et al., 2011), 1 SNPLongevity (Newman et al., 2010), 1 SNPLongevity (Sebastiani et al., 2010), 29 SNPsLumiracoxib-related liver injury (Singer et al., 2010), 1 SNPLung adenocarcinoma (3 studies combined), 6 SNPsLung adenocarcinoma (Hsiung et al., 2010), 1 SNPLung adenocarcinoma (Landi et al., 2009), 5 SNPsLung adenocarcinoma (Miki et al., 2010), 2 SNPsLung cancer (7 studies combined), 14 SNPsLung cancer (Amos et al., 2008), 3 SNPsLung cancer (Broderick et al., 2009), 7 SNPsLung cancer (Hung et al., 2008), 1 SNPLung cancer (Li et al., 2010), 1 SNPLung cancer (Liu et al., 2008), 1 SNPLung cancer (McKay et al., 2008), 2 SNPsLung cancer (Wang et al., 2008), 3 SNPsMajor CVD (Larson et al., 2007), 5 SNPsMajor depressive disorder (8 studies combined), 35 SNPsMajor depressive disorder (Aragam et al., 2011), 5 SNPsMajor depressive disorder (broad) (Shyn et al., 2009), 9 SNPsMajor depressive disorder (Kohli et al., 2011), 1 SNPMajor depressive disorder (Lewis et al., 2010), 4 SNPsMajor depressive disorder (Muglia et al., 2008), 1 SNPMajor depressive disorder (Rietschel et al., 2010), 3 SNPsMajor depressive disorder (Shi et al., 2010), 9 SNPsMajor depressive disorder (Wray et al., 2010), 4 SNPsMajor mood disorders (McMahon et al., 2010), 1 SNPMalaria (Jallow et al., 2009), 3 SNPsMale infertility (Aston et al., 2009), 5 SNPsMale-pattern baldness (2 studies combined), 3 SNPsMale-pattern baldness (Hillmer et al., 2008), 1 SNPMale-pattern baldness (Richards et al., 2008), 2 SNPsMammographic density (Lindström et al., 2011), 1 SNPMean platelet volume (3 studies combined), 27 SNPsMean platelet volume (Meisinger et al., 2008), 3 SNPsMean platelet volume (Soranzo et al., 2009), 27 SNPsMean platelet volume (Soranzo et al., 2009), 1 SNPMelanoma (2 studies combined), 6 SNPsMelanoma (Bishop et al., 2009), 5 SNPsMelanoma (Brown et al., 2008), 1 SNPMenarche (4 studies combined), 44 SNPsMenarche (age at onset) (Elks et al., 2010), 42 SNPsMenarche (age at onset) (Ong et al., 2009), 1 SNPMenarche (age at onset) (Perry et al., 2009), 2 SNPsMenarche (age at onset) (Sulem et al., 2009), 1 SNPMenarche and menopause (age at onset) (He et al., 2009), 6 SNPsMeningococcal disease (Davila et al., 2010), 1 SNPMenopause (age at onset) (Stolk et al., 2009), 13 SNPsMetabolic syndrome (Zabaneh et al., 2010), 18 SNPsMigraine (3 studies combined), 6 SNPsMigraine (Anttila et al., 2010), 1 SNPMigraine (Chasman et al., 2011), 3 SNPsMigraine (Ligthart et al., 2011), 2 SNPsMonocyte early outgrowth colony forming units (Shaw et al., 2011), 3 SNPsMorbidity-free survival (Lunetta et al., 2007), 15 SNPsMortality among heart failure patients (Morrison et al., 2010), 11 SNPsMoyamoya disease (Kamada et al., 2010), 1 SNPMultiple sclerosis (10 studies combined), 43 SNPsMultiple sclerosis (Aulchenko et al., 2008), 1 SNPMultiple sclerosis (Bahlo et al., 2009), 8 SNPsMultiple sclerosis (Briggs et al., 2011), 6 SNPsMultiple sclerosis (Comabella et al., 2008), 1 SNPMultiple sclerosis (Hafler et al., 2007), 6 SNPsMultiple sclerosis (Jager et al., 2009), 15 SNPsMultiple sclerosis (Jakkula et al., 2010), 2 SNPsMultiple sclerosis (Nischwitz et al., 2010), 4 SNPsMultiple sclerosis (Sanna et al., 2010), 2 SNPsMultiple sclerosis (Wang et al., 2011), 3 SNPsMultiple sclerosis--Brain Glutamate Levels (Baranzini et al., 2010), 5 SNPsMyeloproliferative neoplasms (Kilpivaara et al., 2009), 1 SNPMyocardial infarction (3 studies combined), 11 SNPsMyocardial infarction (Aoki et al., 2010), 1 SNPMyocardial infarction (early onset) (Kathiresan et al., 2009), 9 SNPsMyocardial infarction (Helgadottir et al., 2007), 1 SNPMyopia (4 studies combined), 5 SNPsMyopia (pathological) (Li et al., 2010), 1 SNPMyopia (pathological) (Li et al., 2011), 2 SNPsMyopia (pathological) (Nakanishi et al., 2009), 1 SNPMyopia (pathological) (Shi et al., 2011), 1 SNPN-glycan levels (Lauc et al., 2010), 8 SNPsNarcolepsy (3 studies combined), 3 SNPsNarcolepsy (Hallmayer et al., 2009), 1 SNPNarcolepsy (Hor et al., 2010), 2 SNPsNarcolepsy (Miyagawa et al., 2008), 1 SNPNasopharyngeal carcinoma (3 studies combined), 11 SNPsNasopharyngeal carcinoma (Bei et al., 2010), 7 SNPsNasopharyngeal carcinoma (Ng et al., 2009), 1 SNPNasopharyngeal carcinoma (Tse et al., 2009), 3 SNPsNatriuretic peptide levels (M et al., 2011), 3 SNPsNeonatal lupus (Clancy et al., 2010), 5 SNPsNephropathy (3 studies combined), 8 SNPsNephropathy (Feehally et al., 2010), 1 SNPNephropathy (Gharavi et al., 2011), 5 SNPsNephropathy (idiopathic membranous) (Stanescu et al., 2011), 2 SNPsNephrotic syndrome (acquired) (Okamoto et al., 2011), 2 SNPsNeuranatomic and neurocognitive phenotypes (Carless et al., 2011), 1 SNPNeuroblastoma (3 studies combined), 5 SNPsNeuroblastoma (high-risk) (Capasso et al., 2009), 1 SNPNeuroblastoma (Maris et al., 2008), 1 SNPNeuroblastoma (Wang et al., 2010), 3 SNPsNeuroticism (3 studies combined), 7 SNPsNeuroticism (Calboli et al., 2010), 3 SNPsNeuroticism (Oord et al., 2008), 3 SNPsNeuroticism (Shifman et al., 2007), 1 SNPNeutrophil count (Okada et al., 2010), 2 SNPsNicotine dependence (2 studies combined), 3 SNPsNicotine dependence (Bierut et al., 2006), 2 SNPsNicotine dependence (Thorgeirsson et al., 2008), 1 SNPNon-alcoholic fatty liver disease histology (other) (Chalasani et al., 2010), 35 SNPsNon-small cell lung cancer (2 studies combined), 6 SNPsNon-small cell lung cancer (Sato et al., 2010), 3 SNPsNon-small cell lung cancer (Yoon et al., 2010), 3 SNPsNonalcoholic fatty liver disease (Speliotes et al., 2011), 1 SNPNonsyndromic cleft lip with or without cleft palate (3 studies combined), 9 SNPsNonsyndromic cleft lip with or without cleft palate (Birnbaum et al., 2009), 2 SNPsNonsyndromic cleft lip with or without cleft palate (Grant et al., 2009), 2 SNPsNonsyndromic cleft lip with or without cleft palate (Mangold et al., 2009), 6 SNPsNormalized brain volume (Baranzini et al., 2008), 38 SNPsObesity (6 studies combined), 33 SNPsObesity (Dorajoo et al., 2011), 1 SNPObesity (early onset extreme) (Hinney et al., 2007), 1 SNPObesity (extreme) (Cotsapas et al., 2009), 13 SNPsObesity (extreme) (Scherag et al., 2010), 2 SNPsObesity (Meyre et al., 2009), 5 SNPsObesity (Wang et al., 2011), 14 SNPsObesity and osteoporosis (Liu et al., 2009), 2 SNPsObesity-related traits (Scuteri et al., 2007), 3 SNPsOptic disc parameters (Khor et al., 2011), 3 SNPsOptic disc size (rim) (Macgregor et al., 2010), 22 SNPsOsteoarthritis (2 studies combined), 2 SNPsOsteoarthritis (Evangelou et al., 2010), 1 SNPOsteoarthritis (Kerkhof et al., 2010), 1 SNPOsteonecrosis of the jaw (Sarasquete et al., 2008), 1 SNPOsteoporosis (3 studies combined), 9 SNPsOsteoporosis (Guo et al., 2010), 1 SNPOsteoporosis (Hsu et al., 2010), 7 SNPsOsteoporosis (Kou et al., 2011), 1 SNPOsteoporosis-related phenotypes (Karasik et al., 2010), 1 SNPOther erythrocyte phenotypes (Ganesh et al., 2009), 45 SNPsOther metabolic traits (Sabatti et al., 2008), 23 SNPsOtosclerosis (Schrauwen et al., 2009), 1 SNPOvarian cancer (3 studies combined), 10 SNPsOvarian cancer (Bolton et al., 2010), 2 SNPsOvarian cancer (Goode et al., 2010), 7 SNPsOvarian cancer (Song et al., 2009), 1 SNPPaget's disease (2 studies combined), 11 SNPsPaget's disease (Albagha et al., 2010), 4 SNPsPaget's disease (Albagha et al., 2011), 9 SNPsPain (Kim et al., 2009), 3 SNPsPancreatic cancer (3 studies combined), 21 SNPsPancreatic cancer (Amundadottir et al., 2009), 1 SNPPancreatic cancer (Low et al., 2010), 17 SNPsPancreatic cancer (Petersen et al., 2010), 3 SNPsPanic disorder (Otowa et al., 2009), 17 SNPsParkinson's disease (11 studies combined), 46 SNPsParkinson's disease (age of onset) (Latourelle et al., 2009), 5 SNPsParkinson's disease (Edwards et al., 2010), 6 SNPsParkinson's disease (familial) (Pankratz et al., 2008), 1 SNPParkinson's disease (Fung et al., 2006), 3 SNPsParkinson's disease (Hamza et al., 2010), 4 SNPsParkinson's disease (Maraganore et al., 2005), 1 SNPParkinson's disease (Nalls et al., 2011), 10 SNPsParkinson's disease (Saad et al., 2010), 3 SNPsParkinson's disease (Satake et al., 2009), 4 SNPsParkinson's disease (Simón-Sánchez et al., 2009), 10 SNPsParkinson's disease (Spencer et al., 2010), 3 SNPsPartial epilepsies (KasperaviciÅ«te et al., 2010), 6 SNPsPeriodontitis (Schaefer et al., 2009), 1 SNPPeripheral artery disease (Koriyama et al., 2010), 2 SNPsPersonality dimensions (4 studies combined), 20 SNPsPersonality dimensions (Alliey-Rodriguez et al., 2011), 7 SNPsPersonality dimensions (Moor et al., 2010), 2 SNPsPersonality dimensions (Terracciano et al., 2008), 5 SNPsPersonality dimensions (Verweij et al., 2010), 7 SNPsPlasma C4b binding protein levels (Buil et al., 2010), 1 SNPPlasma carotenoid and tocopherol levels (Ferrucci et al., 2009), 2 SNPsPlasma chemerin levels (Bozaoglu et al., 2010), 7 SNPsPlasma coagulation factors (Smith et al., 2010), 2 SNPsPlasma E-selectin levels (Qi et al., 2010), 1 SNPPlasma eosinophil count (Gudbjartsson et al., 2009), 7 SNPsPlasma homocysteine (Paré et al., 2009), 2 SNPsPlasma level of vitamin B12 (Hazra et al., 2008), 1 SNPPlasma levels of liver enzymes (Yuan et al., 2008), 11 SNPsPlasma levels of Protein C (Tang et al., 2010), 4 SNPsPlasma Lp (a) levels (Ober et al., 2009), 1 SNPPlatelet aggregation (Johnson et al., 2010), 15 SNPsPlatelet counts (Ramsuran et al., 2011), 30 SNPsPlatelet function and related traits (Guerrero et al., 2011), 1 SNPPolycystic ovary syndrome (Chen et al., 2010), 5 SNPsPR interval (2 studies combined), 10 SNPsPR interval (Pfeufer et al., 2010), 9 SNPsPR interval (Smith et al., 2011), 1 SNPPrimary biliary cirrhosis (3 studies combined), 28 SNPsPrimary biliary cirrhosis (Hirschfield et al., 2009), 7 SNPsPrimary biliary cirrhosis (Liu et al., 2010), 6 SNPsPrimary biliary cirrhosis (Mells et al., 2011), 21 SNPsPrimary sclerosing cholangitis (Melum et al., 2010), 2 SNPsPrimary tooth development (time to first tooth eruption) (Pillas et al., 2010), 15 SNPsProgranulin levels (Carrasquillo et al., 2010), 1 SNPProstate cancer (12 studies combined), 65 SNPsProstate cancer (Eeles et al., 2008), 12 SNPsProstate cancer (Eeles et al., 2009), 19 SNPsProstate cancer (Gudmundsson et al., 2007), 2 SNPsProstate cancer (Gudmundsson et al., 2007), 2 SNPsProstate cancer (Gudmundsson et al., 2008), 2 SNPsProstate cancer (Gudmundsson et al., 2009), 8 SNPsProstate cancer (Haiman et al., 2011), 1 SNPProstate cancer (Murabito et al., 2007), 14 SNPsProstate cancer (Sun et al., 2009), 1 SNPProstate cancer (Takata et al., 2010), 11 SNPsProstate cancer (Thomas et al., 2008), 7 SNPsProstate cancer (Yeager et al., 2007), 2 SNPsProtein quantitative trait loci (Melzer et al., 2008), 49 SNPsPsoriasis (7 studies combined), 38 SNPsPsoriasis (Capon et al., 2008), 2 SNPsPsoriasis (Ellinghaus et al., 2010), 3 SNPsPsoriasis (Liu et al., 2008), 3 SNPsPsoriasis (Nair et al., 2009), 8 SNPsPsoriasis (Strange et al., 2010), 17 SNPsPsoriasis (Stuart et al., 2010), 8 SNPsPsoriasis (Zhang et al., 2009), 3 SNPsPsoriatic arthritis (Hüffmeier et al., 2010), 3 SNPsPulmonary function (2 studies combined), 14 SNPsPulmonary function (Hancock et al., 2009), 8 SNPsPulmonary function (Repapi et al., 2009), 7 SNPsPulmonary function measures (Wilk et al., 2009), 1 SNPPulmonary function traits (other) (Wilk et al., 2007), 12 SNPsQT interval (4 studies combined), 24 SNPsQT interval (Arking et al., 2006), 1 SNPQT interval (Newton-Cheh et al., 2009), 13 SNPsQT interval (Nolte et al., 2009), 2 SNPsQT interval (Pfeufer et al., 2009), 12 SNPsQuantitative traits (Lowe et al., 2009), 33 SNPsRadiation response (Niu et al., 2010), 12 SNPsRecombination rate (males) (Kong et al., 2008), 2 SNPsRed blood cell traits (Kullo et al., 2010), 13 SNPsRefractive error (2 studies combined), 2 SNPsRefractive error (Hysi et al., 2010), 1 SNPRefractive error (Solouki et al., 2010), 1 SNPRenal cell carcinoma (Purdue et al., 2010), 3 SNPsRenal function and chronic kidney disease (Köttgen et al., 2009), 4 SNPsResponse to acetaminophen (hepatotoxicity) (Moyer et al., 2010), 5 SNPsResponse to antidepressants (Uher et al., 2010), 8 SNPsResponse to antineoplastic agents (Wade et al., 2011), 9 SNPsResponse to antipsychotic therapy (extrapyramidal side effects) (Aberg et al., 2009), 17 SNPsResponse to antipsychotic treatment (3 studies combined), 47 SNPsResponse to antipsychotic treatment (Adkins et al., 2010), 37 SNPsResponse to antipsychotic treatment (Alkelai et al., 2009), 1 SNPResponse to antipsychotic treatment (McClay et al., 2009), 9 SNPsResponse to cerivastatin (Marciante et al., 2011), 1 SNPResponse to citalopram treatment (Garriock et al., 2009), 7 SNPsResponse to clopidogrel therapy (Shuldiner et al., 2009), 1 SNPResponse to diuretic therapy (Turner et al., 2008), 1 SNPResponse to hepatitis C treatment (5 studies combined), 6 SNPsResponse to hepatitis C treatment (Ge et al., 2009), 3 SNPsResponse to hepatitis C treatment (Ochi et al., 2011), 1 SNPResponse to hepatitis C treatment (Suppiah et al., 2009), 1 SNPResponse to hepatitis C treatment (Tanaka et al., 2009), 1 SNPResponse to hepatitis C treatment (Tanaka et al., 2011), 4 SNPsResponse to iloperidone treatment (QT prolongation) (Volpi et al., 2008), 6 SNPsResponse to interferon beta therapy (Weber et al., 2011), 2 SNPsResponse to metformin (Zhou et al., 2010), 1 SNPResponse to platinum-based chemotherapy in non-small-cell lung cancer (Wu et al., 2011), 1 SNPResponse to statin therapy (2 studies combined), 37 SNPsResponse to statin therapy (Barber et al., 2010), 36 SNPsResponse to statin therapy (Link et al., 2008), 1 SNPResponse to TNF antagonist treatment (Liu et al., 2008), 8 SNPsResponse to treatment for acute lymphoblastic leukemia (Yang et al., 2009), 12 SNPsResting heart rate (Eijgelsheim et al., 2010), 10 SNPsRestless legs syndrome (3 studies combined), 6 SNPsRestless legs syndrome (Schormair et al., 2008), 2 SNPsRestless legs syndrome (Stefansson et al., 2007), 1 SNPRestless legs syndrome (Winkelmann et al., 2007), 3 SNPsRetinal vascular caliber (Ikram et al., 2010), 5 SNPsRheumatoid arthritis (10 studies combined), 57 SNPsRheumatoid arthritis (Eleftherohorinou et al., 2011), 5 SNPsRheumatoid arthritis (Freudenberg et al., 2011), 9 SNPsRheumatoid arthritis (Gregersen et al., 2009), 5 SNPsRheumatoid arthritis (Julià et al., 2008), 2 SNPsRheumatoid arthritis (Kochi et al., 2010), 4 SNPsRheumatoid arthritis (Plenge et al., 2007), 3 SNPsRheumatoid arthritis (Plenge et al., 2007), 2 SNPsRheumatoid arthritis (Raychaudhuri et al., 2008), 9 SNPsRheumatoid arthritis (Stahl et al., 2010), 29 SNPsRheumatoid arthritis (Terao et al., 2011), 3 SNPsRibavirin-induced anemia (Ochi et al., 2010), 1 SNPRR interval (heart rate) (Marroni et al., 2009), 34 SNPsSchizophrenia (9 studies combined), 27 SNPsSchizophrenia (Athanasiu et al., 2010), 3 SNPsSchizophrenia (Kirov et al., 2008), 1 SNPSchizophrenia (Lencz et al., 2007), 1 SNPSchizophrenia (O'Donovan et al., 2008), 3 SNPsSchizophrenia (Purcell et al., 2009), 4 SNPsSchizophrenia (Shi et al., 2009), 2 SNPsSchizophrenia (Shifman et al., 2008), 1 SNPSchizophrenia (Stefansson et al., 2009), 7 SNPsSchizophrenia (Sullivan et al., 2008), 6 SNPsSchizophrenia, bipolar disorder and depression (combined) (Huang et al., 2010), 5 SNPsScoliosis (Sharma et al., 2011), 1 SNPSelect biomarker traits (Benjamin et al., 2007), 21 SNPsSelf-rated health (Mosing et al., 2010), 10 SNPsSerum bilirubin levels (Johnson et al., 2009), 8 SNPsSerum calcium (2 studies combined), 11 SNPsSerum calcium (Kapur et al., 2010), 1 SNPSerum calcium (O'Seaghdha et al., 2010), 10 SNPsSerum creatinine (Chambers et al., 2010), 5 SNPsSerum dehydroepiandrosterone sulphate levels (Zhai et al., 2011), 8 SNPsSerum IgE levels (Weidinger et al., 2008), 2 SNPsSerum iron levels (2 studies combined), 5 SNPsSerum iron levels (Pichler et al., 2011), 5 SNPsSerum iron levels (Tanaka et al., 2009), 1 SNPSerum magnesium levels (Meyer et al., 2010), 9 SNPsSerum markers of iron status (3 studies combined), 28 SNPsSerum markers of iron status (Benyamin et al., 2008), 27 SNPsSerum markers of iron status (Benyamin et al., 2009), 4 SNPsSerum markers of iron status (Oexle et al., 2010), 5 SNPsSerum matrix metalloproteinase (Cheng et al., 2009), 4 SNPsSerum metabolites (2 studies combined), 21 SNPsSerum metabolites (Gieger et al., 2008), 16 SNPsSerum metabolites (Illig et al., 2009), 5 SNPsSerum phosphorus levels (Kestenbaum et al., 2010), 5 SNPsSerum phytosterol levels (Teupser et al., 2010), 3 SNPsSerum prostate-specific antigen levels (Gudmundsson et al., 2010), 7 SNPsSerum soluble E-selectin (Paterson et al., 2009), 1 SNPSerum urate (6 studies combined), 17 SNPsSerum urate (Dehghan et al., 2008), 3 SNPsSerum urate (Döring et al., 2008), 1 SNPSerum urate (Li et al., 2007), 1 SNPSerum urate (Vitart et al., 2008), 1 SNPSerum urate (Wallace et al., 2008), 4 SNPsSerum urate (Yang et al., 2010), 11 SNPsSerum uric acid (3 studies combined), 24 SNPsSerum uric acid (Charles et al., 2011), 8 SNPsSerum uric acid (Kolz et al., 2009), 11 SNPsSerum uric acid (McArdle et al., 2008), 7 SNPsSkin pigmentation (Stokowski et al., 2007), 3 SNPsSkin sensitivity to sun (2 studies combined), 10 SNPsSkin sensitivity to sun (Sulem et al., 2007), 14 SNPsSkin sensitivity to sun (Sulem et al., 2008), 6 SNPsSleepiness (Gottlieb et al., 2007), 4 SNPsSmall-cell lung cancer (Wu et al., 2010), 1 SNPSmoking behavior (4 studies combined), 30 SNPsSmoking behavior (Caporaso et al., 2009), 21 SNPsSmoking behavior (Genetics et al., 2010), 5 SNPsSmoking behavior (Liu et al., 2010), 1 SNPSmoking behavior (Thorgeirsson et al., 2010), 5 SNPsSmoking cessation (Uhl et al., 2010), 1 SNPSoluble ICAM-1 (2 studies combined), 4 SNPsSoluble ICAM-1 (Paré et al., 2008), 4 SNPsSoluble ICAM-1 (Paré et al., 2011), 3 SNPsSoluble leptin receptor levels (Sun et al., 2010), 1 SNPSoluble levels of adhesion molecules (Barbalic et al., 2010), 5 SNPsSpeech perception in dyslexia (Roeske et al., 2009), 2 SNPsSphingolipid levels (Hicks et al., 2009), 5 SNPsStroke (2 studies combined), 5 SNPsStroke (Ikram et al., 2009), 1 SNPStroke (Matarín et al., 2007), 4 SNPsSubclinical atherosclerosis traits (other) (O'Donnell et al., 2007), 11 SNPsSuicidal ideation (Perroud et al., 2010), 4 SNPsSuicide attempts in bipolar disorder (Willour et al., 2011), 3 SNPsSystemic lupus erythematosus (8 studies combined), 62 SNPsSystemic lupus erythematosus (Chung et al., 2011), 24 SNPsSystemic lupus erythematosus (Graham et al., 2008), 8 SNPsSystemic lupus erythematosus (Han et al., 2009), 18 SNPsSystemic lupus erythematosus (Harley et al., 2008), 6 SNPsSystemic lupus erythematosus (Hom et al., 2008), 9 SNPsSystemic lupus erythematosus (Kozyrev et al., 2008), 1 SNPSystemic lupus erythematosus (Yang et al., 2010), 2 SNPsSystemic lupus erythematosus (Yang et al., 2010), 1 SNPSystemic sclerosis (Radstake et al., 2010), 4 SNPsSystolic blood pressure (2 studies combined), 23 SNPsSystolic blood pressure (Levy et al., 2009), 18 SNPsSystolic blood pressure (Newton-Cheh et al., 2009), 9 SNPsT-tau (Han et al., 2010), 17 SNPsTanning (Nan et al., 2009), 10 SNPsTelomere length (5 studies combined), 10 SNPsTelomere length (Codd et al., 2010), 1 SNPTelomere length (Gu et al., 2011), 4 SNPsTelomere length (Levy et al., 2010), 4 SNPsTelomere length (Mangino et al., 2009), 1 SNPTelomere length (Prescott et al., 2011), 1 SNPTesticular cancer (2 studies combined), 3 SNPsTesticular cancer (Kanetsky et al., 2009), 1 SNPTesticular cancer (Kanetsky et al., 2011), 2 SNPsTesticular germ cell cancer (Turnbull et al., 2010), 6 SNPsTesticular germ cell tumor (Rapley et al., 2009), 6 SNPsThyroid cancer (Gudmundsson et al., 2009), 2 SNPsThyroid volume (Teumer et al., 2011), 8 SNPsTonometry (Levy et al., 2007), 22 SNPsTotal ventricular volume (Furney et al., 2010), 38 SNPsTriglycerides (7 studies combined), 108 SNPsTriglycerides (Aulchenko et al., 2008), 45 SNPsTriglycerides (Kathiresan et al., 2008), 36 SNPsTriglycerides (Kathiresan et al., 2008), 22 SNPsTriglycerides (Kooner et al., 2008), 4 SNPsTriglycerides (Pollin et al., 2008), 1 SNPTriglycerides (Waterworth et al., 2010), 34 SNPsTriglycerides (Willer et al., 2008), 26 SNPsTuberculosis (Thye et al., 2010), 14 SNPsTwo-hour glucose challenge (Saxena et al., 2010), 5 SNPsType 1 diabetes (7 studies combined), 61 SNPsType 1 diabetes (Barrett et al., 2009), 38 SNPsType 1 diabetes (Cooper et al., 2008), 14 SNPsType 1 diabetes (Grant et al., 2008), 5 SNPsType 1 diabetes (Hakonarson et al., 2007), 4 SNPsType 1 diabetes (Hakonarson et al., 2008), 1 SNPType 1 diabetes (Todd et al., 2007), 12 SNPsType 1 diabetes (Wallace et al., 2009), 2 SNPsType 2 diabetes (20 studies combined), 141 SNPsType 2 diabetes ( et al., 2007), 50 SNPsType 2 diabetes (Below et al., 2011), 1 SNPType 2 diabetes (Parra et al., 2011), 5 SNPsType 2 diabetes (Qi et al., 2010), 1 SNPType 2 diabetes (Salonen et al., 2007), 2 SNPsType 2 diabetes (Saxena et al., 2007), 13 SNPsType 2 diabetes (Scott et al., 2007), 10 SNPsType 2 diabetes (Shu et al., 2010), 4 SNPsType 2 diabetes (Sim et al., 2011), 17 SNPsType 2 diabetes (Sladek et al., 2007), 3 SNPsType 2 diabetes (Steinthorsdottir et al., 2007), 3 SNPsType 2 diabetes (Takeuchi et al., 2009), 7 SNPsType 2 diabetes (Timpson et al., 2008), 8 SNPsType 2 diabetes (Tsai et al., 2010), 3 SNPsType 2 diabetes (Unoki et al., 2008), 3 SNPsType 2 diabetes (Voight et al., 2010), 26 SNPsType 2 diabetes (Yamauchi et al., 2010), 1 SNPType 2 diabetes (Yasuda et al., 2008), 1 SNPType 2 diabetes (Zeggini et al., 2007), 10 SNPsType 2 diabetes (Zeggini et al., 2008), 16 SNPsType 2 diabetes and other traits (Rung et al., 2009), 6 SNPsUlcerative colitis (7 studies combined), 85 SNPsUlcerative colitis (Anderson et al., 2011), 47 SNPsUlcerative colitis (Asano et al., 2009), 7 SNPsUlcerative colitis (Barrett et al., 2009), 13 SNPsUlcerative colitis (Franke et al., 2008), 2 SNPsUlcerative colitis (Franke et al., 2010), 6 SNPsUlcerative colitis (McGovern et al., 2010), 19 SNPsUlcerative colitis (Silverberg et al., 2009), 12 SNPsUpper aerodigestive tract cancers (McKay et al., 2011), 5 SNPsUrinary albumin excretion (2 studies combined), 7 SNPsUrinary albumin excretion (Böger et al., 2011), 1 SNPUrinary albumin excretion (Hwang et al., 2007), 6 SNPsUrinary bladder cancer (2 studies combined), 3 SNPsUrinary bladder cancer (Kiemeney et al., 2008), 2 SNPsUrinary bladder cancer (Kiemeney et al., 2010), 3 SNPsUrinary metabolites (Suhre et al., 2011), 5 SNPsUterine fibroids (Cha et al., 2011), 5 SNPsVaccine-related adverse events (Miller et al., 2011), 2 SNPsVenous thromboembolism (Trégouët et al., 2009), 1 SNPVentricular conduction (Sotoodehnia et al., 2010), 25 SNPsVertical cup-disc ratio (Ramdas et al., 2010), 12 SNPsVitamin D insufficiency (Wang et al., 2010), 3 SNPsVitamin D levels (Ahn et al., 2010), 3 SNPsVitiligo (4 studies combined), 19 SNPsVitiligo (Birlea et al., 2009), 4 SNPsVitiligo (Jin et al., 2010), 10 SNPsVitiligo (Jin et al., 2011), 1 SNPVitiligo (Quan et al., 2010), 4 SNPsVolumetric brain MRI (Seshadri et al., 2007), 19 SNPsWaist circumference (2 studies combined), 12 SNPsWaist circumference (Fox et al., 2007), 5 SNPsWaist circumference (Heard-Costa et al., 2009), 7 SNPsWaist Circumference - Triglycerides (WC-TG) (Kraja et al., 2011), 42 SNPsWaist circumference and related phenotypes (Chambers et al., 2008), 4 SNPsWaist-hip ratio (Heid et al., 2010), 17 SNPsWarfarin maintenance dose (3 studies combined), 10 SNPsWarfarin maintenance dose (Cha et al., 2010), 5 SNPsWarfarin maintenance dose (Cooper et al., 2008), 3 SNPsWarfarin maintenance dose (Takeuchi et al., 2009), 4 SNPsWeight (3 studies combined), 58 SNPsWeight (Croteau-Chonka et al., 2010), 28 SNPsWeight (Johansson et al., 2009), 19 SNPsWeight (Thorleifsson et al., 2008), 31 SNPsWorking memory (McClay et al., 2010), 23 SNPsWrist bone mass (Tan et al., 2010), 1 SNPYKL-40 levels (Ober et al., 2008), 1 SNP

Set Options

Genome version:	hg18hg19
LD threshold, r² (select NA to only show query variants):	0.800.850.900.951.0NA
1000G pilot population for LD calculation:	ASN (CHB+JPT) CEU YRI
Browse ENCODE:	Off On (Please see notes)
Mammalian conservation algorithm:	GERP SiPhy-omega both
Show position relative to:	GENCODE genes RefSeq genes both
Condense lists in table longer than:	012345never condense
Condense indel oligos longer than:	16never condense
Background set for enhancer enrichment analysis:	Affy500KAffy5Affy6Illumina300Illumina650YIllumina660WIllumina1MIlluminaCytoSNPIlluminaOmni1All SNPs in 1KG ASN pilotAll SNPs in 1KG CEU pilotAll SNPs in 1KG YRI pilotAll SNPs in 1KG pilot

Documentation

For usage examples, click here (opens in a pop-up window.)

For details on data sources and methods, see the full documentation (opens in a new window.)

The HaploReg database and web interface were produced by Luke Ward in collaboration with the Computational Biology Group at MIT. HaploReg is hosted by the Broad Institute.

To cite HaploReg, please refer to our publication in Nucleic Acids Research: HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. (PMID:22064851).

Contact: lukeward@mit.edu.